<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ABBOTT LABORATORIES' 1995 FIRST QUARTER FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10-Q FILING. </LEGEND> <MULTIPLIER> 1,000 <CURRENCY> U.S. DOLLAR <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1995 <PERIOD-START> JAN-01-1995 <PERIOD-END> MAR-31-1995 <EXCHANGE-RATE> 1 <CASH> 184,210 <SECURITIES> 65,842 <RECEIVABLES> 1,684,892 <ALLOWANCES> 135,957 <INVENTORY> 1,005,422 <CURRENT-ASSETS> 3,889,835 <PP&E> 7,300,354 <DEPRECIATION> 3,246,977 <TOTAL-ASSETS> 8,751,092 <CURRENT-LIABILITIES> 3,590,608 <BONDS> 285,548 <COMMON> 524,913 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> 3,605,058 <TOTAL-LIABILITY-AND-EQUITY> 8,751,092 <SALES> 2,524,397 <TOTAL-REVENUES> 2,524,397 <CGS> 1,088,911 <TOTAL-COSTS> 1,088,911 <OTHER-EXPENSES> 247,175<F1> <LOSS-PROVISION> 25,393 <INTEREST-EXPENSE> 13,952 <INCOME-PRETAX> 591,850 <INCOME-TAX> 174,596 <INCOME-CONTINUING> 417,254 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 417,254 <EPS-PRIMARY> .52 <EPS-DILUTED> .52 <FN> <F1>OTHER EXPENSES CONSIST OF RESEARCH AND DEVELOPMENT EXPENSES </FN>